1. Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial. Issue 2 (February 2017) Authors: Novak, Petr; Schmidt, Reinhold; Kontsekova, Eva; Zilka, Norbert; Kovacech, Branislav; Skrabana, Rostislav; Vince-Kazmerova, Zuzana; Katina, Stanislav; Fialova, Lubica; Prcina, Michal; Parrak, Vojtech; Dal-Bianco, Peter; Brunner, Martin; Staffen, Wolfgang; Rainer, Michael; Ondrus, Matej; Ropele, S... Journal: Lancet neurology Issue: Volume 16:Issue 2(2017:Feb.) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗